Muutke küpsiste eelistusi

Unfolded Protein Response and Cellular Stress, Part C, Volume 491 [Kõva köide]

Volume editor (Senior Vice President for Research and Associate Provost, Texas Tech Health Sciences Center, TX, USA)
  • Formaat: Hardback, 464 pages, kõrgus x laius: 229x152 mm, kaal: 890 g
  • Sari: Methods in Enzymology
  • Ilmumisaeg: 06-Apr-2011
  • Kirjastus: Academic Press Inc
  • ISBN-10: 012385928X
  • ISBN-13: 9780123859280
Teised raamatud teemal:
  • Formaat: Hardback, 464 pages, kõrgus x laius: 229x152 mm, kaal: 890 g
  • Sari: Methods in Enzymology
  • Ilmumisaeg: 06-Apr-2011
  • Kirjastus: Academic Press Inc
  • ISBN-10: 012385928X
  • ISBN-13: 9780123859280
Teised raamatud teemal:

This volume provides descriptions of the occurrence of the UPR, methods used to assess it, pharmacological tools and other methodological approaches to analyze its impact on cellular regulation. The authors explain how these methods are able to provide important biological insights.

This volume provides descriptions of the occurrence of the UPR, methods used to assess it, pharmacological tools and other methodological approaches to analyze its impact on cellular regulation. The authors explain how these methods are able to provide important biological insights.

Muu info

This volume provides descriptions of the occurrence of the UPR, methods used to assess it, pharmacological tools and other methodological approaches to analyze its impact on cellular regulation
Contributors xiii
Preface xix
Volumes in Series xxi
Section I New Approaches to Studying UPR and Cell Stress
1(380)
1 CFTR Expression Regulation by the Unfolded Protein Response
3(22)
Rafal Bartoszewski
Andras Rab
Lianwu Fu
Sylwia Bartoszewska
James Collawn
Zsuzsa Bebok
1 Introduction
4(2)
2 Methods
6(16)
Acknowledgments
22(1)
References
22(3)
2 GRP78/BiP
Chapter: Modulation of GRP78/BiP in Altering Sensitivity to Chemotherapy
25(12)
Thomas C. Chen
1 Introduction
26(1)
2 Measurement of ER Stress In Vitro and In Vivo
27(9)
3 Conclusion
36(1)
References
36(1)
3 Targeting the Unfolded Protein Response in Cancer Therapy
37(20)
Marina V. Backer
Joseph M. Backer
Prakash Chinnaiyan
1 Introduction
38(1)
2 The UPR and Cancer
38(2)
3 Targeting the UPR
40(10)
4 Combination of EGF-SubA with Other UPR-Targeting Drugs
50(4)
Acknowledgments
54(1)
References
54(3)
4 Large-Scale Analysis of UPR-Mediated Apoptosis in Human Cells
57(16)
Andrew M. Fribley
Justin R. Miller
Tyler E. Reist
Michael U. Callaghan
Randal J. Kaufman
1 Introduction
58(2)
2 Monitoring Proliferation and Caspase Activation Following UPR Activation
60(1)
3 Monitoring the Expression of UPR and Cell Death Target Genes
61(7)
4 DNA Fragmentation Analysis
68(1)
Acknowledgments
69(1)
References
69(4)
5 Quantitative Analysis of Amino Acid Oxidation Markers by Tandem Mass Spectrometry
73(18)
Anuradha Vivekanandan-Giri
Jaeman Byun
Subramaniam Pennathur
1 Introduction
75(1)
2 Experimental Procedures
76(6)
3 Results
82(4)
4 Conclusions
86(1)
Acknowledgments
86(1)
References
87(4)
6 Animal Models in the Study of the Unfolded Protein Response
91(20)
Hemamalini Bommiasamy
Brian Popko
1 Introduction
92(1)
2 Activating Transcription Factor 6
93(1)
3 IRE1/X-Box-Binding Protein-1
94(3)
4 PKR-Like ER Kinase
97(1)
5 elF2α
98(1)
6 ATF4
99(1)
7 Cohp
100(1)
8 GADD34
101(1)
9 P58IPK
102(1)
10 Transgenic Mouse Models for Monitoring ER Stress
102(1)
11 UPR and Lipid Metabollsm
103(1)
12 UPR, Hypoxia, and Cancer
104(1)
13 UPR and Inflammatory-Mediated Demyelination
105(1)
14 Future Challenges
105(1)
References
106(5)
7 Measurement of Fluoride-Induced Endoplasmic Reticulum Stress Using Gaussia Luciferase
111(16)
Ramaswamy Sharma
Masahiro Tsuchiya
Bakhos A. Tannous
John D. Bartlett
1 Introduction
112(2)
2 Properties of Gaussia Luciferase
114(1)
3 Materials
115(3)
4 Procedure
118(5)
5 Conclusions
123(1)
References
124(3)
8 Analysis of Nelfinavir-Induced Endoplasmic Reticulum Stress
127(16)
Ansgar Bruning
1 Introduction
128(1)
2 Obtaining Nelfinavir
129(1)
3 Using Nelfinavir
129(1)
4 Analysis of Nelfinavir-Induced ER Stress
130(4)
5 Immunoblot Analysis
134(1)
6 RT-PCR Analysis
135(6)
7 Conclusions
141(1)
Acknowledgment
142(1)
References
142(1)
9 Using Temporal Genetic Switches to Synchronize the Unfolded Protein Response in Cell Populations In Vivo
143(20)
Alexander Gow
1 Introduction
144(2)
2 Variable Functions of CHOP in the PERK Signaling Pathway
146(1)
3 Mutations in the PLP1 Gene: A Model UPR Disease
147(2)
4 Problems with Current Paradigms Used to Characterize the UPR
149(1)
5 A Novel In Vivo Genetic Switch Solves Many of These Problems
150(7)
6 Generalizing GST to Study Other UPR Diseases
157(1)
Acknowledgments
157(1)
References
158(5)
10 Glycoprotein Maturation and the UPR
163(20)
Andreas J. Hulsmeier
Michael Welti
Thierry Hennet
1 Introduction
163(2)
2 N-glycosylation
165(10)
3 O-glycosylation
175(6)
Acknowledgment
181(1)
References
181(2)
11 Monitoring and Manipulating Mammalian Unfolded Protein Response
183(16)
Nobuhiko Hiramatsu
Victory T. Joseph
Jonathan H. Lin
1 Introduction
184(1)
2 Monitoring Mammalian UPR
185(4)
3 Chemical-Genetic Manipulation of Mammalian UPR
189(5)
4 Concluding Remarks
194(1)
Acknowledgments
195(1)
References
195(4)
12 A Screen for Mutants Requiring Activation of the Unfolded Protein Response for Viability
199(18)
Guillaume Thibault
Davis T. W. Ng
1 Introduction
200(2)
2 Screening for Mutants That Require UPR Activation for Viability
202(7)
3 Cloning and Sequencing per Genes
209(3)
4 Monitoring the LPR Activity
212(1)
5 SGA Database
213(1)
6 Media Recipes
214(1)
7 Closing Remarks
214(1)
Acknowledgment
215(1)
References
215(2)
13 Signaling Pathways of Proteostasis Network Unrevealed by Proteomic Approaches on the Understanding of Misfolded Protein Rescue
217(18)
Patricia Gomes-Alves
Sofia Neves
Deborah Penque
1 Introduction
218(1)
2 2DE-Based Proteomics Approach Analysis to Study Protein Expression Profile
219(1)
3 Experimental Design
220(1)
4 2D Gel Electrophoresis
221(2)
5 Protein Identification by MS
223(2)
6 Biochemical Validation
225(1)
7 Data Mining and Publication
226(5)
Acknowledgments
231(1)
References
231(4)
14 Decreased Secretion and Unfolded Protein Response Upregulation
235(26)
Carissa L. Young
Theresa Yuraszeck
Anne S. Robinson
1 Introduction
236(1)
2 Heterologous Protein Expression
237(1)
3 Quality Control Mechanisms of the Secretory Pathway
238(1)
4 Endoplasmic Reticulum Export and Trafficking
239(1)
5 Experimental Systems to Evaluate Expression, UPR, and Secretory Processing
239(1)
6 S. cerevisiae Strains Used for Optimal Expression
240(1)
7 Plasmid Design
241(2)
8 Evaluation of Heterologous Protein Expression
243(5)
9 Statistical Analysis of Microarray Results
248(9)
Acknowledgment
257(1)
References
257(4)
15 Measuring Signaling by the Unfolded Protein Response
261(32)
David J. Cox
Natalie Strudwick
Ahmed A. Ali
Adrienne W. Paton
James C. Paton
Martin Schroder
1 Introduction
262(4)
2 Methods to Induce the UPR
266(1)
3 Measuring Signaling by the UPR in S. cerevisiae
266(10)
4 Measuring Signaling by the UPR in Mammalian Cells
276(12)
Acknowledgments
288(1)
References
289(4)
16 Quantitative Measurement of Events in the Mammalian Unfolded Protein Response
293(16)
Jie Shang
1 Introduction
294(1)
2 Cell Culture and ER Stress Inducers
295(1)
3 Northern Blots for GRP78/BiP and EDEM
296(3)
4 RT-PCR Analysis of XBP1 mRNA Splicing
299(3)
5 Immunoblotting and Measurement of ATF6
302(1)
6 Measurement of Inhibition of Protein Synthesis
302(1)
7 Measurement of Stimulation of LLO Extension
303(1)
8 Calculations of Transcript Accumulation, Signal Activation, and Correlation
304(1)
9 Conclusion
305(1)
Acknowledgments
306(1)
References
306(3)
17 Regulation of Immunoglobulin Synthesis, Modification, and Trafficking by the Unfolded Protein Response: A Quantitative Approach
309(18)
Adi Drori
Boaz Tirosh
1 Introduction
310(2)
2 Isolation of Splenic B Cells and Infection Thereof by Retroviruses
312(4)
3 Measurement of Protein Synthesis in Plasma Cells
316(4)
4 Measurement of Ig Mislocalization in Primary B Cells
320(4)
Acknowledgments
324(1)
References
324(3)
18 Use of Chemical Genomics in Assessment of the UPR
327(16)
Sakae Saito
Akihiro Tomida
1 Introduction
328(1)
2 Assessment of the Activation of UPR Transcriptional Program in Cancer Cell
329(5)
3 Gene Expression Signature-Based Identification of UPR Modulators
334(4)
4 Future Perspective of Chemical Genomics in UPR Research
338(1)
Acknowledgments
339(1)
References
339(4)
19 Small GTPase Signaling and the Unfolded Protein Response
343(18)
Marion Bouchecareilh
Esther Marza
Marie-Elaine Caruso
Eric Chevet
1 Introduction
344(2)
2 Materials and Methods
346(2)
3 Monitoring the Unfolded Protein Response
348(5)
4 Monitoring Small GTPase Activity
353(3)
5 Pharmacological and Genetic Modulation of UPR and GTPase Signaling
356(2)
Acknowledgments
358(1)
References
358(3)
20 Inhibitors of Advanced Glycation and Endoplasmic Reticulum Stress
361(20)
Reiko Inagi
1 Introduction
362(1)
2 Advanced Glycation and Its Pathophysiology
363(1)
3 Measurement of Advanced Glycation
364(5)
4 Link Between Advanced Glycation and ER Stress
369(4)
5 Effects of Advanced Glycation Inhibitor Against ER Stress
373(4)
6 Conclusion
377(1)
Acknowledgments
377(1)
References
377(4)
Author Index 381(18)
Subject Index 399
P. Michael Conn is the Senior Vice President for Research and Associate Provost, Texas Tech Health Sciences Center. He is The Robert C. Kimbrough, Professor of Internal Medicine and Cell Biology/Biochemistry. He was previously Director of Research Advocacy and Professor of Physiology and Pharmacology, Cell Biology and Development and Obstetrics and Gynecology at Oregon Health and Science University and Senior Scientist of the Oregon National Primate Research Center (ONPRC). He served for twelve years as Special Assistant to the President and Associate Director of the ONPRC. After receiving a B.S. degree and teaching certification from the University of Michigan (1971), a M.S. from North Carolina State University (1973), and a Ph.D. degree from Baylor College of Medicine (1976), Conn did a fellowship at the NIH, then joined the faculty in the Department of Pharmacology, Duke University Medical Center where he was promoted to Associate Professor in 1982. In 1984, he became Professor and Head of Pharmacology at the University of Iowa College of Medicine, a position he held for eleven years. Conn is known for his research in the area of the cellular and molecular basis of action of gonadotropin releasing hormone action in the pituitary and therapeutic approaches that restore misfolded proteins to function. His work has led to drugs that have benefitted humans and animals. Most recently, he has identified a new class of drugs, pharmacoperones, which act by regulating the intracellular trafficking of receptors, enzymes and ion channels. He has authored or co-authored over 350 publications in this area and written or edited over 200 books, including texts in neurosciences, molecular biology and endocrinology. Conn has served as the editor of many professional journals and book series (Endocrinology, Journal of Clinical Endocrinology and Metabolism, Endocrine, Methods, Progress in Molecular Biology and Translational Science and Contemporary Endocrinology). Conn served on the National Board of Medical Examiners, including two years as chairman of the reproduction and endocrinology committee. The work of his laboratory has been recognized with a MERIT award from the NIH, the J.J. Abel Award of the American Society for Pharmacology and Experimental Therapeutics, the Weitzman, Oppenheimer and Ingbar Awards of the Endocrine Society, the National Science Medal of Mexico (the Miguel Aleman Prize) and the Stevenson Award of Canada. He is the recipient of the Oregon State Award for Discovery, the Media Award of the American College of Neuropsychopharmacology and was named a distinguished Alumnus of Baylor College of Medicine in 2012. Conn is a previous member of Council for the American Society for Cell Biology and the Endocrine Society and is a prior President of the Endocrine Society, during which time he founded the Hormone Foundation and worked with political leadership to heighten the publics awareness of diabetes. Conns students and fellows have gone on to become leaders in industry and academia. He is an elected member of the Mexican Institute of Medicine and a fellow of the American Association for the Advancement of Science. He is the co-author of The Animal Research War (2008) and many articles for the public and academic community on the value of animal research and the dangers posed by animal extremism. His op/eds have appeared in The Washington Post, The LA Times, The Wall Street Journal, the Des Moines Register, and elsewhere. Conn consults with organizations that are influenced by animal extremism and with universities and companies facing challenges from these groups.